In 64 HBsAg-negative, anti-HBc-positive adults randomised after allo-HCT, HepB vaccination did not significantly reduce HBV reactivation vs no vaccination (estimated 19.8% vs 37.9% at 18 months; P=.205). No reactivation occurred after vaccine response.
RCTn = 64
Onozawa et al. Vaccine-Induced Anti-HBs Response is Associated with Protection Against Hepatitis B Virus Reactivation after Allogeneic Hematopoietic Cell Transplantation: A Randomized Trial